フィトケミカルの生理機能におけるcGMPの関与を中心に研究。
cGMPの幅広い生体保護作用に着目し、これらを介した
機能性食品の研究や、新たな治療標的の探索等を実施。
My research focuses on the role of cGMP in the physiological effects of phytochemicals.
Our group previously identified several molecules including Tollip and demonstrated that those signaling pathways-induced by cGMP play crucial role in the resilience of the human body. To understand the physiological role of the cGMP in the beneficial effect of several compounds including phytochemicals, we use several disease mouse models including orthotopic tumor implantation model (Osteosarcoma, MPM, Pancreatic cancer, Lung cancer, breast cancer, etc) and other disease models (Obesity, SLE, IBD, ARDS, IgAN, NASH, PAH, Parkinson’s disease, Rheumatoid arthritis). Based on our findings, our recent clinical study found that GT-gH (our proposed polyphenols combination based by cGMP induction) suppressed weight gain and BMI increase in human subjects (UMIN000040109 Placebo-controlled, randomized, double-blind). My goal is to establish the novel strategy to prevent and treat difficult disease.
キーワード:cGMP、フィトケミカル、ケミカルバイオロジー、免疫学、腫瘍学
2021.12~2022.06.
熊添 基文(くまぞえ もとふみ) | データ更新日:2024.04.08 |
主な研究テーマ
従事しているプロジェクト研究
cGMPの生体調節作用
2018.04~2022.06
cGMPの生体保護作用の解明とその調節法の開発.
2018.04~2022.06
cGMPの生体保護作用の解明とその調節法の開発.
研究業績
主要著書
主要原著論文
1. | Kumazoe Motofumi, Miyamoto Emi, Oka Chihiro, Kondo Miyuki, Yoshitomi Ren, Onda Hiroaki, Shimada Yu, Fujimura Yoshinori, Tachibana Hirofumi., miR-12135 ameliorates liver fibrosis accompanied with downregulation of ITGA11., iScience, 10.1016/j.isci.2023.108730, 108730, 2023.12, [URL]. |
2. | Yamashita Mai*, Kumazoe Motofumi* (Equal Contribution), Onda Hiroaki, Hiroi Shun, Shimada Yu, Fujimura Yoshinori, Tachibana Hirofumi., PPAR/PDK4 pathway is involved in the anticancer effects of cGMP in pancreatic cancer., Biochem Biophys Res Commun., 10.1016/j.bbrc.2023.06.043., 672, 154-160, 2023.09. |
3. | Kumazoe Motofumi, Ogawa Fumiyo, Hikida Ai, Shimada Yu, Yoshitomi Ren, Watanabe Ryoya, Onda Hiroaki, Fujimura Yoshinori, Tachibana Hirofumi., Plant miRNA osa-miR172d-5p suppressed lung fibrosis by targeting Tab1., Sci Rep, 10.1038/s41598-023-29188-6, 2128, 2023.02, [URL]. |
4. | Kumazoe Motofumi, Fujimura Yoshinori, Yoshitomi Ren, Shimada Yu, Tachibana Hirofumi., Fustin, a Flavanonol, Synergically Potentiates the Anticancer Effect of Green Tea Catechin Epigallocatechin-3-O-Gallate with Activation of the eNOS/cGMP Axis., Journal of agricultural and food chemistry, 10.1021/acs.jafc.1c07567, 70, 11, 3458-3466, 2022.03. |
5. | Kumazoe Motofumi, Takamatsu Kanako, Horie Fuyumi, Yoshitomi Ren, Hamagami Hiroki, Tanaka Hiroshi, Fujimura Yoshinori, Tachibana Hirofumi., Methylated (-)-epigallocatechin 3-O-gallate potentiates the effect of split vaccine accompanied with upregulation of Toll-like receptor 5., Scientific reports, 11, 1, 23101-23101, 2021.11. |
6. | Kumazoe Motofumi, Tanaka Yasutake, Yoshitomi Ren, Marugame Yuki, Lee Kwan-Woo, Onda Hiroaki, Fujimura Yoshinori , Yonekura Madoka, Shimamoto Yasuyo, Tachibana Hirofumi., Glucosyl-hesperidin enhances the cyclic guanosine monophosphate-inducing effect of a green tea polyphenol EGCG., Journal of natural medicines, 10.1007/s11418-021-01538-6, 75, 4, 1037-1042, 2021.09. |
7. | Tanaka Yasutake*, Kumazoe Motofumi* (Equal Contribution), Onda Hiroaki, Fujimura Yoshinori, Tachibana Hirofumi., Time-dependent increase of plasma cGMP concentration followed by oral EGCG administration in mice., Food Bioscience, https://doi.org/10.1016/j.fbio.2021.101017, 41, 101017-101017, 2021.06. |
8. | Kumazoe Motofumi, Kadomatsu Mai, Bae Jaehoon, Otsuka Yushi, Fujimura Yoshinori, Tachibana Hirofumi., Src Mediates Epigallocatechin-3-O-Gallate-Elicited Acid Sphingomyelinase Activation., Molecules (Basel, Switzerland), 10.3390/molecules25225481, 25, 22, 2020.11. |
9. | Kumazoe Motofumi, Hiroi Shun, Tanimoto Yousuke, Miyakawa Jyunichi, Yamanouchi Maasa, Suemasu Yumi, Yoshitomi Ren, Murata Motoki, Fujimura Yoshinori, Takahashi Takashi, Tanaka Hiroshi, Tachibana Hirofumi., Cancer cell selective probe by mimicking EGCG., Biochemical and biophysical research communications, 10.1016/j.bbrc.2020.03.021, 525, 4, 974-981, 2020.05. |
10. | Bae Jaehoon*, Kumazoe Motofumi* (Equal Contribution), Takeuchi Chieri, Hidaka Shiori, Fujimura Yoshinori, Tachibana Hirofumi., Epigallocatechin-3-O-gallate induces acid sphingomyelinase activation through activation of phospholipase C., Biochemical and biophysical research communications, 10.1016/j.bbrc.2019.09.102, 520, 1, 186-191, 2019.11. |
11. | Kumazoe Motofumi, Yamashita Mai, Nakamura Yuki, Takamatsu Kanako, Bae Jaehoon, Yamashita Shuya, Yamada Shuhei, Onda Hiroaki, Nojiri Takashi, Kangawa Kenji, Tachibana Hirofumi., Green Tea Polyphenol EGCG Upregulates Tollip Expression by Suppressing Elf-1 Expression., JOURNAL OF IMMUNOLOGY, 10.4049/jimmunol.1601822, 199, 9, 3261-3269, 2017.11. |
12. | Tsukamoto Shuntaro*, Kumazoe Motofumi* (Equal Contribution), Huang Yuhui, Lesnick Connie, Kay E. Neil, Shanafelt D. Tait, Tachibana Hirofumi., SphK1 inhibitor potentiates the anti-cancer effect of EGCG on leukaemia cells., BRITISH JOURNAL OF HAEMATOLOGY, 10.1111/bjh.14119, 178, 1, 155-158, 2017.07. |
13. | Kumazoe Motofumi, Takai Mika, Hiroi Shun, Takeuchi Chieri, Kadomatsu Mai, Nojiri Takashi, Onda Hiroaki, Bae Jaehoon, Huang Yuhui, Takamatsu Kanako, Yamashita Shuya, Kangawa Kenji, Tachibana Hirofumi., The FOXO3/PGC-1 beta signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma., JOURNAL OF BIOLOGICAL CHEMISTRY, 10.1074/jbc.M116.772111, 292, 26, 10813-10823, 2017.06. |
14. | Kumazoe Motofumi, Takai Mika, Bae Jaehoon, Hiroi Shun, Huang Yuhui, Takamatsu Kanako, Won Yeong Seon, Yamashita Mai, Hidaka Shiori, Yamashita Shuya, Yamada Shuhei, Murata Motoki, Tsukamoto Shuntaro, Tachibana Hirofumi., FOXO3 is essential for CD44 expression in pancreatic cancer cells., ONCOGENE, 10.1038/onc.2016.426, 36, 19, 2643-2654, 2017.05. |
15. | Kumazoe Motofumi, Takai Mika, Hiroi Shun, Takeuchi Chieri, Yamanouchi Maasa, Nojiri Takashi, Onda Hiroaki, Bae Jaehoon, Huang Yuhui, Takamatsu Kanako, Yamashita Shuya, Yamada Shuhei, Kangawa Kenji, Takahashi Takashi, Tanaka Hiroshi, Tachibana Hirofumi., PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma., SCIENTIFIC REPORTS, 10.1038/s41598-017-02162-9, 7, 1, 1917, 2017.05. |
16. | Kumazoe Motofumi, Nakamura Yuki, Yamashita Mai, Suzuki Takashi, Takamatsu Kanako, Huang Yuhui, Bae Jaehoon, Yamashita Shuya, Murata Motoki, Yamada Shuhei, Shinoda Yuki, Yamaguchi Wataru, Toyoda Yui, Tachibana Hirofumi., Green Tea Polyphenol Epigallocatechin-3-gallate Suppresses Toll-like Receptor 4 Expression via Up-regulation of E3 Ubiquitin-protein Ligase RNF216., JOURNAL OF BIOLOGICAL CHEMISTRY, 10.1074/jbc.M116.755959, 292, 10, 4077-4088, 2017.03. |
17. | Huang Yuhui*, Kumazoe Motofumi* (Equal Contribution), Bae Jaehoon, Yamada Shuhei, Takai Mika, Hidaka Shiori, Yamashita Shuya, Kim Yoonhee, Won Yeongseon, Murata Motoki, Tsukamoto Shuntaro, Tachibana Hirofumi., Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells., ONCOLOGY REPORTS, 10.3892/or.2015.4086, 34, 3, 1162-1168, 2015.09. |
18. | Kumazoe Motofumi, Fujimura Yoshinori, Hidaka Shiori, Kim Yoonhee, Murayama Kanako, Takai Mika, Huang Yuhui , Yamashita Shuya, Murata Motoki, Miura Daisuke, Wariishi Hiroyuki, Maeda-Yamamoto Mari, Tachibana Hirofumi., Metabolic Profiling-based Data-mining for an Effective Chemical Combination to Induce Apoptosis of Cancer Cells., SCIENTIFIC REPORTS, 10.1038/srep09474, 5, 2015.03. |
19. | Kumazoe Motofumi, Tsukamoto Shuntaro, Lesnick Connie, Kay E. Neil, Yamada Koji, Shanafelt D. Tait, Tachibana Hirofumi., Vardenafil, a clinically available phosphodiesterase inhibitor, potentiates the killing effect of EGCG on CLL cells., BRITISH JOURNAL OF HAEMATOLOGY, 168, 4, 610-613, 2015.02. |
20. | Kumazoe Motofumi, Kim Yoonhee, Bae Jaehoon, Takai Mika, Murata Motoki, Suemasu Yumi, Sugihara Kaori, Yamashita Shuya, Tsukamoto Shuntaro, Huang Yuhui, Nakahara Kanami, Yamada Koji, Tachibana Hirofumi. , Phosphodiesterase 5 inhibitor acts as a potent agent sensitizing acute myeloid leukemia cells to 67-kDa laminin receptor-dependent apoptosis., FEBS LETTERS, 10.1016/j.febslet.2013.07.041, 587, 18, 3052-3057, 2013.09. |
21. | Kumazoe Motofumi, Sugihara Kaori, Tsukamoto Shuntaro, Huang Yuhui, Tsurudome Yukari, Suzuki Takashi, Suemasu Yumi, Ueda Naoki, Yamashita Shuya, Kim Yoonhee, Yamada Koji, Tachibana Hirofumi., 67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis., JOURNAL OF CLINICAL INVESTIGATION, 10.1172/JCI64768, 123, 2, 787-799, 2013.02. |
主要総説, 論評, 解説, 書評, 報告書等
主要学会発表等
学会活動
受賞
9. The 4th International Conference on O-CHA (Tea) Culture and Science Symposium Poster Award., ICOS, 2010.10.
平成24年度日本栄養・食糧学会 九州・沖縄支部 優秀発表者賞, 日本栄養・食糧学会 九州・沖縄支部大会, 2012.09.
日本農芸化学会 トピックス賞, 日本農芸化学会, 2013.03.
平成25年度日本農芸化学会西日本支部奨励賞 (学生), 日本農芸化学会西日本支部, 2014.01.
平成25年度 生物資源環境科学府賞, 九州大学大学院生物資源環境科学府, 2014.03.
育志賞, 日本学術振興会, 2014.02.
ネスレ栄養科学学会(NNCJ)2014 年度論文賞, Nestlé Nutrition Council Japan, 2014.11.
日本農芸化学会トピックス賞, 日本農芸化学会, 2017.03.
がん研究助成奨励金, 日本対がん協会, 2018.03.
日本農芸化学会 トピックス賞, 日本農芸化学会, 2021.03.
令和3年度日本農芸化学会西日本支部奨励賞, 日本農芸化学会西日本支部, 2022.01.
研究資金
科学研究費補助金の採択状況(文部科学省、日本学術振興会)
2020年度~2022年度, 基盤研究(C), 代表, 血管内皮細胞を起点とする抗炎症機構の解明.
2015年度~2017年度, 若手研究(B), 代表, 天然物の作用機構解明に基づく新規がん細胞致死機構の探索.
2018年度~2019年度, 若手研究, 代表, cGMP の癌幹細胞抑制作用の機構解明.
2018年度~2020年度, 基盤研究(C), 分担, ANPの組織繊維化抑制作用の機序解明と肺線維症治療への応用.
2020年度~2022年度, 基盤研究(C), 代表, 血管内皮細胞を起点とする抗炎症機構の解明.
2015年度~2016年度, 若手研究(B), 連携, 食品因子センシング調節を介した食品間の機能的相互作用の解明.
2014年度~2016年度, 特別研究員奨励費, 代表, 緑茶カテキンEGCGをリード化合物とするがん幹細胞を殺傷する新規化合物の作製 (日本学術振興会PD).
2011年度~2013年度, 特別研究員奨励費, 代表, EGCG のプローブ化によるがん医療への応用 (日本学術振興会DC1).
競争的資金(受託研究を含む)の採択状況
2017年度~2019年度, がんの子供を守る会, 代表, 小児がんに関する研究 (具体的内容は非公開).
2017年度~2018年度, 武田科学振興財団, 代表, cGMP の抗がん作用機構の解明と臨床応用への基盤確立.
2017年度~2018年度, 興和生命科学振興財団, 代表, 癌幹細胞に対する直ちに臨床応用可能な治療戦略の確立.
本データベースの内容を無断転載することを禁止します。